<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>20(11)</volume><submitter>Fu Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Prognostic assessment plays a crucial role in guiding clinical management and treatment decisions for gastric cancer patients. The enrichment characteristics of 5-hydroxymethylcytosine (5hmC) in circulating cell-free DNA (cfDNA) has emerged as potential prognostic epigenetic markers.&lt;h4>Methods&lt;/h4>Using 5hmC-Seal combined with next-generation sequencing (NGS), we profiled the genome-wide distribution of 5hmC in plasma cfDNA samples from 51 gastric cancer patients. Prognostic biomarkers were selected via random survival forest and Cox proportion hazards models, and a prognostic model was subsequently constructed.&lt;h4>Results&lt;/h4>Seven prognostic biomarker genes were identified, and the 7-gene prognostic model demonstrated a concordance index (C-index) of 0.892 (95% CI = 0</pubmed_abstract><journal>PloS one</journal><pagination>e0335654</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12633862</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>5-hydroxymethylcytosines from circulating cell-free DNA as noninvasive prognostic markers for gastric cancer.</pubmed_title><pmcid>PMC12633862</pmcid><pubmed_authors>Jiang J</pubmed_authors><pubmed_authors>Fu C</pubmed_authors><pubmed_authors>Cao X</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Cao D</pubmed_authors><pubmed_authors>Fu Y</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors><pubmed_authors>Jia Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>5-hydroxymethylcytosines from circulating cell-free DNA as noninvasive prognostic markers for gastric cancer.</name><description>&lt;h4>Background&lt;/h4>Prognostic assessment plays a crucial role in guiding clinical management and treatment decisions for gastric cancer patients. The enrichment characteristics of 5-hydroxymethylcytosine (5hmC) in circulating cell-free DNA (cfDNA) has emerged as potential prognostic epigenetic markers.&lt;h4>Methods&lt;/h4>Using 5hmC-Seal combined with next-generation sequencing (NGS), we profiled the genome-wide distribution of 5hmC in plasma cfDNA samples from 51 gastric cancer patients. Prognostic biomarkers were selected via random survival forest and Cox proportion hazards models, and a prognostic model was subsequently constructed.&lt;h4>Results&lt;/h4>Seven prognostic biomarker genes were identified, and the 7-gene prognostic model demonstrated a concordance index (C-index) of 0.892 (95% CI = 0</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-05-19T03:22:20.878Z</modification><creation>2026-05-19T03:11:55.88Z</creation></dates><accession>S-EPMC12633862</accession><cross_references><pubmed>41264656</pubmed><doi>10.1371/journal.pone.0335654</doi></cross_references></HashMap>